These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21701990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The brain as a target for inflammatory processes and neuroprotective strategies.
    Skaper SD.
    Ann N Y Acad Sci; 2007 Dec; 1122():23-34. PubMed ID: 18077562
    [Abstract] [Full Text] [Related]

  • 4. Glatiramer acetate for the treatment of multiple sclerosis: evidence for a dual anti-inflammatory and neuroprotective role.
    Liblau R.
    J Neurol Sci; 2009 Dec; 287 Suppl 1():S17-23. PubMed ID: 20106343
    [Abstract] [Full Text] [Related]

  • 5. Neuroprotective potential beyond immunoregulation of helminth infection as a therapeutic target in multiple sclerosis.
    Zheng XP, Zhang HL, Li HF, Zhang MZ, Qiu W, Hu XQ.
    Med Hypotheses; 2012 Jan; 78(1):95-7. PubMed ID: 22047987
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Future research directions in multiple sclerosis therapies.
    Greenberg BM, Calabresi PA.
    Semin Neurol; 2008 Feb; 28(1):121-7. PubMed ID: 18256992
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP, Kellaway LA, Lahiri DK, Kotwal GJ.
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [Abstract] [Full Text] [Related]

  • 10. Neuroprotection in multiple sclerosis.
    Karussis D, Grigoriadis S, Polyzoidou E, Grigoriadis N, Slavin S, Abramsky O.
    Clin Neurol Neurosurg; 2006 Mar; 108(3):250-4. PubMed ID: 16413962
    [Abstract] [Full Text] [Related]

  • 11. Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma.
    Delgado M, Ganea D.
    FASEB J; 2003 Oct; 17(13):1922-4. PubMed ID: 12923064
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The neuroprotective effect of modified Yeoldahanso-tang via autophagy enhancement in models of Parkinson's disease.
    Bae N, Ahn T, Chung S, Oh MS, Ko H, Oh H, Park G, Yang HO.
    J Ethnopharmacol; 2011 Mar 24; 134(2):313-22. PubMed ID: 21172413
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Limiting and repairing the damage in multiple sclerosis.
    Compston A.
    Schweiz Med Wochenschr; 1993 Jun 05; 123(22):1145-52. PubMed ID: 8322049
    [Abstract] [Full Text] [Related]

  • 17. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis.
    Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H.
    Neurol Sci; 2006 Mar 05; 27 Suppl 1():S1-7. PubMed ID: 16708174
    [Abstract] [Full Text] [Related]

  • 18. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS, Lipton SA.
    J Neurochem; 2006 Jun 05; 97(6):1611-26. PubMed ID: 16805772
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective role of testosterone in the nervous system.
    Białek M, Zaremba P, Borowicz KK, Czuczwar SJ.
    Pol J Pharmacol; 2004 Jun 05; 56(5):509-18. PubMed ID: 15591638
    [Abstract] [Full Text] [Related]

  • 20. Stem cell-based cell therapy in neurological diseases: a review.
    Kim SU, de Vellis J.
    J Neurosci Res; 2009 Aug 01; 87(10):2183-200. PubMed ID: 19301431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.